Imaging Tumor Necrosis with Ferumoxytol-Reference-Cited by-同舟云学术

Imaging Tumor Necrosis with Ferumoxytol

Published:2015-11-16 Issue:11 Volume:10 Page:e0142665
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Aghighi Maryam,Golovko Daniel,Ansari Celina,Marina Neyssa M.,Pisani Laura,Kurlander Lonnie,Klenk Christopher,Bhaumik Srabani,Wendland Michael,Daldrup-Link Heike E.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles;HE Daldrup-Link;Clinical Cancer Research,2011

2. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer;MG Harisinghani;New England Journal of Medicine,2003

3. Breast Cancers: MR Imaging of folate-receptor expression with the folate-specific nanoparticle P1133 1;R Meier;Radiology,2010

4. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study;EA Neuwelt;Neurosurgery,2007

5. Detection of hepatocellular carcinoma: comparison of Gd-DTPA-and ferumoxides-enhanced MR imaging;G Simon;European radiology,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of severe anaphylactic reaction after administration of diagnostic-dose ferumoxytol in a pediatric patient;Pediatric Radiology;2024-06-22

2. Iron Oxide Nanoparticles: A Mighty Pioneering Diagnostic Tool But Is It Really Safe for Carcinoma and Neurodegenerative Diseases?;Toxicity of Nanoparticles - Recent Advances and New Perspectives;2024-01-10

3. Green magnetic nanoparticles: a comprehensive review of recent progress in biomedical and environmental applications;Journal of Materials Science;2023-12-21

4. Chiral Gd-DOTA as a Versatile Platform for Hepatobiliary and Tumor Targeting MRI Contrast Agents;Journal of Medicinal Chemistry;2023-10-19

5. Translatable Drug-Loaded Iron Oxide Nanophore Sensitizes Murine Melanoma Tumors to Monoclonal Antibody Immunotherapy;ACS Nano;2023-03-27